CP99,219与DU-6859a、环丙沙星、氧氟沙星、左氧氟沙星、洛美沙星、妥舒沙星、司帕沙星及格帕沙星对青霉素敏感和耐药肺炎球菌的活性比较。 - Suppr

Suppr

超能文献

Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.

作者信息

Pankuch G A, Jacobs M R, Appelbaum P C

出版信息

J Antimicrob Chemother. 1995 Jan;35(1):230-2. doi: 10.1093/jac/35.1.230.

DOI:10.1093/jac/35.1.230

PMID:7768776

Abstract

摘要

相似文献

Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.CP99,219与DU-6859a、环丙沙星、氧氟沙星、左氧氟沙星、洛美沙星、妥舒沙星、司帕沙星及格帕沙星对青霉素敏感和耐药肺炎球菌的活性比较。

J Antimicrob Chemother. 1995 Jan;35(1):230-2. doi: 10.1093/jac/35.1.230.

Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococci.

Drugs. 1995;49 Suppl 2:235-7. doi: 10.2165/00003495-199500492-00053.

Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.采用时间杀菌法比较CP 99,219（曲伐沙星）与环丙沙星、司帕沙星、克林沙星、洛美沙星及头孢呋辛对10株青霉素敏感和青霉素耐药肺炎球菌的活性。

J Antimicrob Chemother. 1996 Jan;37(1):77-84. doi: 10.1093/jac/37.1.77.

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.DU-6859a、环丙沙星、左氧氟沙星、司帕沙星、头孢噻肟、亚胺培南及万古霉素对9株青霉素敏感及耐药肺炎球菌活性的最低抑菌浓度（MIC）及时间杀菌研究

Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362.

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.吉米沙星对德国肺炎链球菌分离株的体外活性

Chemotherapy. 2001 Mar-Apr;47(2):104-9. doi: 10.1159/000048508.

In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.左氧氟沙星及其他三种氟喹诺酮类药物对青霉素敏感和耐药肺炎链球菌的体外抑菌活性

J Antimicrob Chemother. 1999 Jun;43 Suppl C:9-14. doi: 10.1093/jac/43.suppl_3.9.

Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.测定肺炎链球菌对环丙沙星、左氧氟沙星、曲伐沙星、格帕沙星和吉米沙星的耐药频率。

Eur J Clin Microbiol Infect Dis. 2001 Dec;20(12):883-5. doi: 10.1007/s10096-001-0636-6.

Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.曲伐沙星、加替沙星、克林沙星、司帕沙星、左氧氟沙星和环丙沙星在体外感染模型中对青霉素耐药肺炎链球菌的活性。

Antimicrob Agents Chemother. 2000 Mar;44(3):598-601. doi: 10.1128/AAC.44.3.598-601.2000.

Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.

J Antimicrob Chemother. 1998 Dec;42(6):803-6. doi: 10.1093/jac/42.6.803.

In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.氟喹诺酮类药物（加替沙星、左氧氟沙星和曲伐沙星）及其他七种抗生素对肺炎链球菌的体外活性

Braz J Infect Dis. 2001 Apr;5(2):50-2. doi: 10.1590/s1413-86702001000200001. Epub 2001 Aug 3.

引用本文的文献

Clinical evaluation of the tolerability and efficacy of trovafloxacin compared with sparfloxacin in the treatment of lower respiratory tract infections.比较托氟沙星与司帕沙星治疗下呼吸道感染的耐受性和疗效的临床评估。

Clin Drug Investig. 2000;20(2):95-100. doi: 10.2165/00044011-200020020-00004.

The new fluoroquinolones: A critical review.新型氟喹诺酮类药物：批判性综述。

Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394.

Comparative antipneumococcal activities of sulopenem and other drugs.舒洛培南与其他药物的抗肺炎球菌活性比较。

Antimicrob Agents Chemother. 2009 Jun;53(6):2239-47. doi: 10.1128/AAC.01531-08. Epub 2009 Mar 23.

In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.新型广谱氟喹诺酮类药物DC-159a与其他药物相比，对药敏和耐药肺炎球菌的体外活性。

Antimicrob Agents Chemother. 2008 Jan;52(1):77-84. doi: 10.1128/AAC.01229-07. Epub 2007 Oct 15.

Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.新型喹诺酮类药物DW - 224a与其他八种药物的抗肺炎球菌活性比较。

Antimicrob Agents Chemother. 2006 Jun;50(6):2064-71. doi: 10.1128/AAC.00153-06.

Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.新型喹诺酮类药物DK-507k的抗肺炎球菌活性与其他10种药物活性的比较。

Antimicrob Agents Chemother. 2003 Dec;47(12):3815-24. doi: 10.1128/AAC.47.12.3815-3824.2003.

Antipneumococcal activity of BMS 284756 compared to those of six other agents.与其他六种药物相比，BMS 284756的抗肺炎球菌活性。

Antimicrob Agents Chemother. 2002 Jan;46(1):251-4. doi: 10.1128/AAC.46.1.251-254.2002.

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.厄他培南（MK-0826）与其他药物相比的抗肺炎球菌活性。

Antimicrob Agents Chemother. 2002 Jan;46(1):42-6. doi: 10.1128/AAC.46.1.42-46.2002.

Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.新型氟喹诺酮类药物对耐环丙沙星肺炎链球菌的活性。

Antimicrob Agents Chemother. 2001 Jun;45(6):1654-9. doi: 10.1128/AAC.45.6.1654-1659.2001.

Streptococcus pneumoniae: Activity of Newer Agents Against Penicillin-Resistant Strains.肺炎链球菌：新型药物对青霉素耐药菌株的活性

Curr Infect Dis Rep. 1999 Apr;1(1):13-21. doi: 10.1007/s11908-999-0004-8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验